RFG
TEVA icon

Range Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Range Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Sell
10,785
-252
-2% -$8.39K 0.1% 169
2026
Q1 		$332K Buy
+11,037
New +$355K 0.11% 163
2024
Q3 		– Sell
-61,777
Closed -$1M – 166
2024
Q2 		$1M Buy
61,777
+5,278
+9% +$81.3K 0.51% 66
2024
Q1 		$797K Buy
+56,499
New +$712K 0.41% 81

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Range Financial Group's TEVA Position: Q2 2026 in Review

Range Financial Group reduced its Teva Pharmaceuticals (TEVA) stake by 2.3% in Q2 2026, selling an estimated $8.39K and leaving 10,785 shares worth $365K. The position accounts for 0.1% of the portfolio, ranked #169.

Range Financial Group first reported a position in TEVA in Q1 2024 and has held it in 4 quarters since. The position peaked at $1M in Q2 2024. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Range Financial Group held 10,785 shares of Teva Pharmaceuticals worth $365K as of Q2 2026.
  • Range Financial Group sold 252 Teva Pharmaceuticals shares in Q2 2026, an estimated $8.39K.
  • Teva Pharmaceuticals made up 0.1% of Range Financial Group's portfolio in Q2 2026, its #169 holding.
  • Range Financial Group first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Range Financial Group's Teva Pharmaceuticals position peaked at $1M in Q2 2024.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.